article thumbnail

Drug Channels News Roundup, April 2022: 340Boom, 340B Profits for Pharmacies & PBMs, Fixing Insulin, Walgreens’ Robots, and Doctors’ Day

Drug Channels

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day!

article thumbnail

Running Through Life with Type 1 Diabetes

Worldwide Clinical Trials

I was diagnosed with Type 1 diabetes, an autoimmune disease where the pancreas stops producing insulin, unlike Type 2 diabetes, where the body doesn’t produce enough or use it properly. There’s no cure and managing Type 1 requires multiple daily insulin injections (MDI) or an insulin pump.

Insulin 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52
article thumbnail

Novo Nordisk launches first smart insulin pens for NHS patients

pharmaphorum

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8

Insulin 52
article thumbnail

Medtronic Introduces New Minimed 770G For Type 1 Diabetes

XTalks

This is an insulin pump system that offers the company’s most advanced SmartGuard technology. ” The pancreas of people with type 1 diabetes cannot produce insulin. “Being able to offer my patients an insulin pump system that provides safe, automated insulin delivery and smartphone connectivity is incredibly beneficial.”.

Insulin 98
article thumbnail

National Diabetes Month 2024: Take Charge of Tomorrow — Preventing Diabetes Health Problems

XTalks

Diabetes, a chronic condition marked by high blood glucose levels due to insulin issues, brings complications like heart disease, stroke, neuropathy and diabetic foot ulcers. Abbot also joined Medtronic to pair its sensors with the latter’s automated insulin delivery (AID) systems. million undiagnosed and 115.9

Insulin 105
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market.

Drugs 295